Nuveen Asset Management, LLC Dice Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$25.86 - $46.71 $2.4 Million - $4.34 Million	92,823 Added 70.63%	224,252 $10.4 Million
Q1 2023 May 15, 2023	SELL	$26.05 - $32.31 $320,675 - $397,736	-12,310 Reduced 8.56%	131,429 $3.77 Million
Q4 2022 Feb 14, 2023	BUY	$19.77 - $42.23 $1.09 Million - $2.33 Million	55,240 Added 62.42%	143,739 $4.48 Million
Q3 2022 Nov 14, 2022	SELL	$14.97 - $22.65 $24,011 - $36,330	-1,604 Reduced 1.78%	88,499 $1.8 Million
Q2 2022 Aug 15, 2022	BUY	$13.19 - $22.1 $765,798 - $1.28 Million	58,059 Added 181.19%	90,103 $1.4 Million
Q1 2022 May 16, 2022	BUY	$14.54 - $25.02 $159,649 - $274,719	10,980 Added 52.13%	32,044 $613,000
Q4 2021 Feb 14, 2022	BUY	$22.41 - $37.54 $472,044 - $790,742	21,064 New	21,064 $533,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.